NEW YORK (GenomeWeb) – The Translational Genomics Research Institute and George Mason University today said that they will integrate genomics, proteomics, and molecular profiling in an alliance aimed at finding personalized treatments for patients.

The TGen-George Mason Molecular Medicine Alliance will pair TGen's genomics capabilities with research carried out at George Mason's Center for Applied Proteomics and Molecular Medicine. Their goal is to apply and study personalized methods for treating patients with cancer and other life-threatening conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.